UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 316

Sortiert nach

Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast

Molecular biology reports, 2024-12, Vol.51 (1), p.661-661

2024

Link zum Volltext

Verfügbarkeit prüfen

Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma in CheckMate -9DW Trial

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer

Business Wire, 2024-06-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Power-Doppler-based NH002 microbubble sonoporation with chemotherapy relieves hypoxia and enhances the efficacy of chemotherapy and immunotherapy for pancreatic tumors

Scientific reports, 2024-06, Vol.14 (1), p.8532-8532

2024

Link zum Volltext

Verfügbarkeit prüfen

Anti-angiogenesis efficacy of the aqueous extract of Allium sativum and its combination with melatonin in an animal model: in vivo and ex vivo studies

Farmacija, 2024-06 (3), p.1

Obaid, Khalid Ali

2024

Link zum Volltext

Verfügbarkeit prüfen

YAP promotes the early development of temporomandibular joint bony ankylosis by regulating mesenchymal stem cell function

Scientific reports, 2024-06, Vol.14 (1), p.12704-12704

2024

Link zum Volltext

Verfügbarkeit prüfen

Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer

Business Wire, 2024-06-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Crocin's role in modulating MMP2/TIMP1 and mitigating hypoxia-induced pulmonary hypertension in mice

Scientific reports, 2024-06, Vol.14 (1), p.12716-12716

2024

Link zum Volltext

Verfügbarkeit prüfen

Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Improving dermal fibroblast-to-epidermis communications and aging wound repair through extracellular vesicle-mediated delivery of Gstm2 mRNA

Journal of nanobiotechnology, 2024-06, Vol.22 (1), p.307-307

2024

Link zum Volltext

Verfügbarkeit prüfen

ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care

PR newswire, 2024-06-02

2024

Link zum Volltext

Verfügbarkeit prüfen

Ultrasound-targeted microbubble destruction technology delivering [beta]-klotho to the heart enhances FGF21 sensitivity and attenuates heart remodeling post-myocardial infarction

International journal of molecular medicine, 2024-06, Vol.53 (6), p.1

2024

Link zum Volltext

Verfügbarkeit prüfen

Azoxymethane-induced carcinogenesis-like model of mouse intestine and mouse embryonic stem cell-derived intestinal organoids

Molecular biology reports, 2024-06, Vol.51 (1), p.704-704

2024

Link zum Volltext

Verfügbarkeit prüfen

Long non-coding RNA MEG3 knockdown represses airway smooth muscle cells proliferation and migration via sponging miR-143-3p/FGF9 in asthma

Journal of cardiothoracic surgery, 2024-06, Vol.19 (1), p.314-314

2024

Link zum Volltext

Verfügbarkeit prüfen

ESPR 2024

Pediatric radiology, 2024-06, Vol.54 (Suppl 2), p.169-288

2024

Link zum Volltext

Verfügbarkeit prüfen

Integrated oral microgel system ameliorates renal fibrosis by hitchhiking co-delivery and targeted gut flora modulation

Journal of nanobiotechnology, 2024-06, Vol.22 (1), p.305-305

2024

Link zum Volltext

Verfügbarkeit prüfen

Homeostasis and evolution in relation to regeneration and repair

The Journal of physiology, 2024-06, Vol.602 (11), p.2627-2648

2024

Link zum Volltext

Verfügbarkeit prüfen

Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Dihydroartemisinin alleviates doxorubicin‐induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy

The FASEB journal, 2024-05, Vol.38 (10), p.e23677-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

A rare case report: multiple intrahepatic masses in a pediatric patient with citrin deficiency

Discover. Oncology, 2024-05, Vol.15 (1), p.200-200

2024

Link zum Volltext

Verfügbarkeit prüfen

EVOKE-01 Study Results in Metastatic NSCLC to Be Presented at an Oral Session at ASCO 2024

Business Wire, 2024-05-31

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 316

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 30 Tagen

PublikationsformBerichte

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast

Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma in CheckMate -9DW Trial

Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer

Power-Doppler-based NH002 microbubble sonoporation with chemotherapy relieves hypoxia and enhances the efficacy of chemotherapy and immunotherapy for pancreatic tumors

Anti-angiogenesis efficacy of the aqueous extract of Allium sativum and its combination with melatonin in an animal model: in vivo and ex vivo studies

YAP promotes the early development of temporomandibular joint bony ankylosis by regulating mesenchymal stem cell function

Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer

Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer

Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer

Crocin's role in modulating MMP2/TIMP1 and mitigating hypoxia-induced pulmonary hypertension in mice

Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care

Improving dermal fibroblast-to-epidermis communications and aging wound repair through extracellular vesicle-mediated delivery of Gstm2 mRNA

ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy

IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo

Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care

Ultrasound-targeted microbubble destruction technology delivering [beta]-klotho to the heart enhances FGF21 sensitivity and attenuates heart remodeling post-myocardial infarction

Azoxymethane-induced carcinogenesis-like model of mouse intestine and mouse embryonic stem cell-derived intestinal organoids

Long non-coding RNA MEG3 knockdown represses airway smooth muscle cells proliferation and migration via sponging miR-143-3p/FGF9 in asthma

ESPR 2024

Integrated oral microgel system ameliorates renal fibrosis by hitchhiking co-delivery and targeted gut flora modulation

Homeostasis and evolution in relation to regeneration and repair

Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression

Dihydroartemisinin alleviates doxorubicin‐induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy

A rare case report: multiple intrahepatic masses in a pediatric patient with citrin deficiency

EVOKE-01 Study Results in Metastatic NSCLC to Be Presented at an Oral Session at ASCO 2024

Aktive Filter

Suchergebnisse filtern